Improved anesthesia for deep surface-induced hypothermia: the halothane-diethyl ether azeotrope

Area of Science:

• Cardiovascular Surgery
• Anesthesiology
• Veterinary Medicine

Background:

• Deep surface hypothermia with total circulatory arrest is a critical procedure in open-heart surgery.
• Traditional anesthetic agents like ether in 100% oxygen (O2) pose risks, including arrhythmias and postoperative complications.
• Evaluating novel anesthetic combinations is crucial for improving patient outcomes during complex cardiac procedures.

Purpose of the Study:

• To assess the efficacy and safety of the halothane-diethyl ether azeotrope as an anesthetic agent for deep surface hypothermia with total circulatory arrest.
• To compare the outcomes of using the azeotrope in 100% O2 versus 95% O2 with 5% carbon dioxide (CO2).
• To evaluate the potential of this non-explosive anesthetic agent in pediatric cardiac surgery.

Main Methods:

• Dogs were subjected to deep surface hypothermia and total circulatory arrest using the halothane-diethyl ether azeotrope in different gas mixtures.
• Physiological parameters, including arrhythmias, cooling/rewarming rates, and resuscitation success, were monitored.
• Postoperative neurological status and blood lactate levels were assessed to evaluate clinical outcomes.

Main Results:

• Anesthetic administration in 100% O2 led to significant atrial arrhythmias and ventricular fibrillation in dogs.
• Using the azeotrope in 95% O2 with 5% CO2 resulted in smoother cooling, easier resuscitation, and reduced motor disturbances.
• Dogs treated with the 95% O2/5% CO2 mixture showed lower blood lactates and improved postoperative clinical status compared to the standard ether/100% O2 method.
• Limited clinical trials in infants undergoing congenital cardiac defect repair showed favorable responses.

Conclusions:

• The halothane-diethyl ether azeotrope in 95% O2 and 5% CO2 offers a safer and more effective anesthetic approach for deep hypothermia and circulatory arrest.
• This anesthetic method significantly reduces perioperative complications and improves recovery compared to traditional agents.
• The non-explosive nature and improved outcomes warrant further investigation of this azeotrope in clinical settings.